Education, Science, Technology, Innovation and Life
Open Access
Sign In

Progress in etiology and diagnosis of granulomatous mastitis

Download as PDF

DOI: 10.23977/medsc.2022.030118 | Downloads: 5 | Views: 651


Can Li 1, Ruilin Guo 2


1 College of Medical Technology, Shaanxi University of Traditional Chinese Medicine, Xianyang 712000, China
2 The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China

Corresponding Author

Can Li


The non-lactation mastitis is a chronic inflammatory disease. In accordance with the causes can be divided into specific mastitis and non-specific mastitis. Non-specific mastitis is common in granulomatous mastitis and plasma cell mastitis. Due to the unclear etiology and pathological mechanism, the treatment effect is not ideal. And it is easy to delay recurrence, which makes the patient in a long-term dilemma. In recent years, the incidence of granulomatous mastitis increased year by year. Scholars at home and abroad have made in-depth studies on the etiology and pathological mechanism of granulomatous mastitis. There are mainly two views, autoimmune reaction mechan and the factors of bacterial infection. New risk factors are being identified. This article reviews the etiology and diagnosis of granulomatous mastitis.


granulomatous mastitis, idiopathic granulomatous mastitis, C.kroppenstedtii corynebacterium, etiology


Can Li, Ruilin Guo, Progress in etiology and diagnosis of granulomatous mastitis. MEDS Clinical Medicine (2022) Vol. 3: 101-107. DOI:


[1] Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma [J]. Am J Clin Pathol, 1972, 58(6): 642-646.
[2] Calis H, Karabeyoglu SM. Follow-up of granulomatous mastitis with monitoring versus surgery [J]. Breast Dis, 2017, 37: 69-72. 
[3] Wolfrum A, Kümmel S, Theuerkauf I, et al. Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge [J]. Breast Care (Basel), 2018, 13(6): 413-418.
[4] Johnstone KJ, Robson J, Cherian SG, et al. Cystic neutrophilic granulomatous mastitis associated with Corynebacterium including Corynebacterium kroppenstedtii [J]. Pathology, 2017, 49: 405-412.
[5] Davis J, Cocco D, Matz S, et al. Re-evaluating if observation continues to be the best management of idiopathic granulomatous mastitis [J]. Surgery, 2019, 166(6): 1176-1180.
[6] Sahin C, Ucpinar BA. Idiopathic granulomatous mastitis in a male breast following intravesical Bacille Calmette–Guerin treatment [J]. J Infect Public Health, 2020, 13(5): 830-832.
[7] Grover H, Grover SB , Goyal P, et al. Clinical and imaging features of idiopathic granulomatous mastitis - The diagnostic challenges and a brief review [J]. Clin Imaging, 2020, 69: 126-132.
[8] Hiu-Kan Ip K, Koch K, Lamont D. Granulomatosis with polyangiitis: a life-threatening cause of granulomatous mastitis [J]. ANZ J Surg, 2020. 
[9] Kıvılcım T, Altıntoprak F, Memiş B, et al. Role of Bacteriological Agents in Idiopathic Granulomatous Mastitis: Real or Not? [J]. Eur J Breast Health, 2019, 15(1): 32-36.
[10] Cserni G, Szajki K.Granulomatous Lobular Mastitis Following Drug-Induced Galactorrhea and Blunt Trauma [J]. Breast J, 1999, 5(6): 398-403.
[11] Koksal H. Human leukocyte antigens class I and II in patients with idiopathic granulomatous mastitis [J]. Am J Surg, 2019, 218(3): 605-608.
[12] Tang A, Dpminguez DA, Edquilang JK, et al. Granulomatous Mastitis: Comparison of Novel Treatment of Steroid Injection and Current Management [J]. Surg Res, 2020, 254: 300-305.
[13] Postolova A, Troxell ML, Wapnir IL, Methotrexate in the Treatment of Idiopathic Granulomatous Mastitis [J]. J Rheumatol, 2020, 47(6): 924-927. 
[14] Kehribar DY, Duran TI, Polat AK, Effectiveness of Methotrexate in Idiopathic Granulomatous Mastitis Treatment [J]. Am J Med Sci, 2020, S0002-9629(20)30203-2.
[15] Binelli C, Lorimier G, Bertrand G, et al. Granulomatous mastitis and corynebacteria infection. Two cases reports [J]. J Gynecol Obstet Biol Reprod (Paris), 1996, 25(1): 27-32.
[16] Yu HJ, Deng H, Ma J, et al. Clinical metagenomic analysis of bacterial communities in breast abscesses of granulomatous mastitis [J]. Int J Infect Dis, 2016, 53: 30-33.
[17] Saraiya N, Corpuz M. Corynebacterium kroppenstedtii: a challenging culprit in breast abscesses and granulomatous mastitis [J]. Curr Opin Obstet Gynecol, 2019, 31(5): 325-332.
[18] Chen H, YU H, Xie S, et al. Detection of Corynebacterium in granulomatous mastitis abscess [J]. Chin J Breast Dis, 2019, 13(4): 207-211.
[19] Ying Wong SC, Rosana W S Poon R W S, Foo al. Novel selective medium for the isolation of Corynebacterium kroppenstedtiibfrom heavily colonised clinical specimens [J]. J Clin Pathol, 2018, 71(9): 781-786.
[20] Wang L, Jorns JM. Cystic neutrophilic granulomatous mastitis: Corynebacterium species-associated infection with distinct histology [J]. Clin Microbiol Infect, 2020, S1198-743X (20) 30383-9.
[21] Wang J, Xu H, Li Z, et al. Pathogens in patients with granulomatous lobular mastitis [J]. Int J Infect Dis, 2019, 81: 123-127.
[22] Merino-Alado R, Pineda J, Rasquin JH, et al. Granulomatous mastitis due to coinfection with Histoplasma sp. and Paracoccidioides sp.: A case report [J]. Med Mycol Case Rep, 2020, 27: 52-54.
[23] Yuan Y, Zhang J, Li J. The clinicopathological characteristics and potential underlying causes of granulomatous lobular mastitis [J]. Breast J, 2020, 26(5): 1099-1100.
[24] Li J, McGregor HP. Idiopathic granulomatous mastitis associated with hyperprolactinemia: A nonoperative approach [J]. Breast J, 2017, 23(6): 742-744.
[25] Agrawal A, Pabolu S. A Rare Case of Idiopathic Granulomatous Mastitis in a Nulliparous Woman with Hyperprolactinemia [J]. Cureus. 2019, 11(5): e4680.
[26] Li Y, Zhou X. Clinical characteristics of non-lactation mastitis high-risk constitution [J]. E-journal of Integrated Traditional and Western Medicine Cardiovascular Disease.2019, 7(33): 62-62+66.
[27] Yazigi G, Trieu BH, Landis, et al. Granulomatous Mastitis: A Rare Case with Sjogren’s Syndrome and Complications [J]. Cureus, 2019, 11(8): e5359.
[28] Goulabchand R, Hafidi A, de Perre PV, et al. Mastitis in Autoimmune Diseases: Review of the Literature, Diagnostic Pathway, and Pathophysiological Key Players [J]. J Clin Med, 2020, 9(4): 958.
[29] Bercot B, Kannengiesser C, Oudin C, et al. First description of NOD2variant associated with defective neutrophil responses in a woman with granulomatous mastitis related to cornebacteria [J]. J Clin Microbiol, 2009, 47(9): 3034-3037.
[30] Sánchez-Miño JI, Ortiz Rodríguez AM, Orozco LG, et al. [Breast tuberculosis: a case report] [J]. Rev Peru Med Exp Salud Publica, 2018, 35(2): 333-337.
[31] Agarwal C, Singh K, Pujani M, et al. Are all Granulomatous Mastitis Cases Tuberculous?: A Study on the Role of Cytology in Evaluation of Granulomatous Mastitis [J]. Turk Patoloji Derg, 2019, 35(2): 128-133.
[32] Pinto Paz ME, Bueno Lazo L, Carrera Palao D, et al. Efficacy and safety of oncoplastic surgery plus drug therapy for chronic tuberculous granulomatous mastitis [J]. Int J Tuberc Lung Dis, 2020, 24(6): 585-590.
[33] Kriegsmann M, Gomez C, Heil J, et al. IgG4-related sclerosing mastitis in a 49-year-old patient with multiple, tumor-like nodules-Diagnostic accuracy of core needle biopsy [J]. Breast J, 2019, 25(6): 1251-1253.
[34] Allen SG, Soliman AS, Toy T, et al. Chronic Mastitis in Egypt and Morocco: Differentiating between Idiopathic Granulomatous Mastitis and IgG4‐Related Disease[J]. Breast, 2016, 22(5): 501-509.
[35] Cetin K MD, Sıkar HE, Güllüoğlu BM. Idiopathic granulomatous mastitis with erythema nodosum: Is it a variant of clinical presentation indicating treatment resistance? A retrospective cohort study [J]. Breast J, 2020, 19.
[36] Jiang L, Li X, Sun B, et al. Clinicopathological features of granulomatous lobular mastitis and mammary duct ectasia. Oncol Lett., 2020, 19(1): 840-848.
[37] Koksal H,Vatansev H, Artac H, et al. The clinical value of interleukins-8, -10, and -17 in idiopathic granulomatous mastitis [J]. Clin Rheumatol, 2020, 39(5): 1671-1677.
[38] Saydam M, Yilmaz KB, Sahin M, et al. New Findings on Autoimmune Etiology of Idiopathic Granulomatous Mastitis: Serum IL-17, IL-22 and IL-23 Levels of Patients [J]. J Invest Surg, 2020: 1-5.
[39] Eyerich K, Dimartino V, Cavani A. IL-17 and IL-22 in immunity: driving protection and pathology. Eur J Immunol, 2017, 47(4): 607–614.
[40] Yigitbasi MR, Guntas G, Atak T, et al. The Role of Interleukin-33 as an Inflammatory Marker in Differential Diagnosis of Idiopathic Granulomatous Mastitis and Breast Cancer [J]. J Invest Surg,2017, 30(4): 272-276.
[41] Basim P, Argun D. A Comparison of the Circulating Endocan Levels between the Inflammatory and Malignant Diseases of the Same Organ: The Breast [J]. J Invest Surg, 2020, 1-7.

Downloads: 3870
Visits: 167005

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.